Qtron Investments »

Halozyme Therapeutics shares owned by Qtron Investments

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Qtron Investments from 13F filings

Historical chart of Qtron Investments investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Qtron Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Qtron Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $482k 7.2k 67.30
2021-06-30 $255k 5.6k 45.34
2021-03-31 $234k 5.6k 41.61